NeoTract, the acquired business of Teleflex (TFX), continues to perform impressively.
Within Molecular Diagnostics, Myriad Genetics (MYGN) registers strong sales for EndoPredict, myChoice CDx and BRACAnalysis CDx.
SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SurModics (SRDX) delivered earnings and revenue surprises of 180.00% and 1.57%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Q2 2020 Surmodics Inc Earnings Call
Organigram (OGI) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.
Medtronic's (MDT) new cannula will complement its entire portfolio of balloon kyphoplasty products, including Kyphon Xpander II Inflatable Bone Tamps.
Surmodics (SRDX) registered growth in one of its core units, Invitro Diagnostics, in Q2.
Investor confidence is high in Surmodics (SRDX) stock, thanks to solid prospects.
IDEXX (IDXX) notes a significant improvement in U.S. clinical visit trends across major regions.
By buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...
Investors continue to be optimistic about Chemed (CHE) on robust segmental growth.
Surmodics announced Gordon Weber has joined Surmodics as Senior Vice President of Legal, General Counsel and Secretary.
Based on a brief questionnaire remotely filled by the patient, the MaskSelector tool recommends the best suitable ResMed (RMD) mask for patients.
Surmodics announced results for its second quarter and suspended financial guidance for fiscal 2020, and will host a webcast at 4 p.m. CT today.
Hologic (HOLX) expects to boost testing capacity by combining its manufacturing ability for the latest EUA of test with its largest installed base of high-throughput molecular instruments.
Image source: The Motley Fool. SurModics (NASDAQ: SRDX)Q2 2020 Earnings CallApr 29, 2020, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day and welcome to the Surmodics second-quarter fiscal 2020 earnings conference call.
This partnership is expected to boost AMN Healthcare's (AMN) Other Workforce Solutions segment.
Henry Schein (HSIC) registers dismal performance within Dental business on suspension of non-emergency procedures in response to the pandemic.
Surmodics will issue its second quarter fiscal 2020 earnings after the market closes on April 29 and webcast its conference call at 4 p.m. CT.